ChemicalBook >> CAS DataBase List >>Ibrutinib Impurity 9
Ibrutinib Impurity 9
- CAS No.
- 2068022-09-1
- Chemical Name:
- Ibrutinib Impurity 9
- Synonyms
- Ibrutinib Impurity 3-d5;N-(1-((S)-1-acryloylpiperidin-3-yl)-;Ibrutinib Impurity 3-d5 (PCI-45227-d5);Ibrutinib Impurity 3-d5 (PCI-45227-d5)(Mixture of Diastereomers);1-((R)-3-(4-Amino-3-(4-(phenoxy-d5)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one;1-[(3R)-3-[4-amino-3-[4-(2,3,4,5,6-pentadeuteriophenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2,3-dihydroxypropan-1-one
- CBNumber:
- CB13879189
- Molecular Formula:
- C25H21D5N6O4
- Molecular Weight:
- 479.54254889
- MDL Number:
- MOL File:
- 2068022-09-1.mol
Last updated:2025-04-18 09:51:42
| Product description | Number | Pack Size | Price |
| Dihydrodiol-Ibrutinib-d5 | CS-0134702 | 1mg | $1018 |
| Dihydrodiol-Ibrutinib-d5 | CS-0134702 | 5mg | $2817 |
Ibrutinib Impurity 9 Chemical Properties,Uses,Production
Uses
Dihydrodiol-Ibrutinib-d5 is the deuterium labeled Dihydrodiol-Ibrutinib (HY-100659). Dihydrodiol-Ibrutinib is a dihydrodiol active metabolite of Ibrutinib (HY-10997), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib[1].
References
[1] Sridhar Veeraraghavan,et al. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study. J Pharm Biomed Anal DOI:10.1016/j.jpba.2014.11.041
Ibrutinib Impurity 9 Preparation Products And Raw materials
Raw materials
Preparation Products
Ibrutinib Impurity 9 Suppliers
Global( 6)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| HX Pharmaceutical technology co., LTD | 15671363360 | 494267389@qq.com | China | 3635 | 58 |
| CHINA ISOTOPE CO., LIMITED | 02151600108 13062666369 | info@isotopechem.com | China | 4719 | 58 |
| https://www.shachemlin.cn/ | 68080707 15021879576 | ming-jiao.wu@chemlin.com.cn | China | 9050 | 58 |
| Hubei Moco Chemical Co., Ltd. | 18627753421; 18627756402 | 3001051413@qq.com | China | 20013 | 58 |
| TLC Pharmaceutical Standards Ltd. | 18012923235 | chinasales04@tlcstandards.com.cn | China | 8143 | 58 |
| Supplier | Advantage |
|---|---|
| HX Pharmaceutical technology co., LTD | 58 |
| CHINA ISOTOPE CO., LIMITED | 58 |
| https://www.shachemlin.cn/ | 58 |
| Hubei Moco Chemical Co., Ltd. | 58 |
| TLC Pharmaceutical Standards Ltd. | 58 |
2068022-09-1(Ibrutinib Impurity 9)Related Search:
Ceritinib (LDK378)
Cabozantinib
LOXO-101
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine
(S)-Ibrutinib
1of3
1-[(3R)-3-[4-amino-3-[4-(2,3,4,5,6-pentadeuteriophenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2,3-dihydroxypropan-1-one
Ibrutinib Impurity 3-d5
N-(1-((S)-1-acryloylpiperidin-3-yl)-
Ibrutinib Impurity 3-d5 (PCI-45227-d5)(Mixture of Diastereomers)
1-((R)-3-(4-Amino-3-(4-(phenoxy-d5)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one
Ibrutinib Impurity 3-d5 (PCI-45227-d5)
2068022-09-1




